
The risk of tumor with the use of recombinant human bone morphogenetic proteins
Author(s) -
У. Ф. Мухаметов,
S.V. Lyulin,
D.Yu. Borzunov,
Rinat Sufianov,
Ilgiz Gareev
Publication year - 2022
Publication title -
genij ortopedii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 3
eISSN - 2542-131X
pISSN - 1028-4427
DOI - 10.18019/1028-4427-2022-28-4-592-598
Subject(s) - bone morphogenetic protein , carcinogenesis , bone morphogenetic protein 2 , cancer research , medicine , bone morphogenetic protein 7 , recombinant dna , bioinformatics , biology , in vitro , cancer , genetics , gene